MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Revenue History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Sales | ₹8,749 Cr | ₹7,782 Cr | ₹6,214 Cr | ₹5,872 Cr | ₹4,980 Cr |
What is the latest Revenue of MANKIND PHARMA ?
Year | Revenue |
---|---|
Mar2023 | ₹8,749 Cr |
Mar2022 | ₹7,782 Cr |
Mar2021 | ₹6,214 Cr |
Mar2020 | ₹5,872 Cr |
Mar2019 | ₹4,980 Cr |
How is Revenue of MANKIND PHARMA Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2023 | ₹8,749 Cr | 12.44 | |
Mar2022 | ₹7,782 Cr | 25.22 | |
Mar2021 | ₹6,214 Cr | 5.83 | |
Mar2020 | ₹5,872 Cr | 17.91 | |
Mar2019 | ₹4,980 Cr | - |
Compare Revenue of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹85,970.8 Cr | 1.5% | -8.1% | 53.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹350,339.0 Cr | -0.5% | -3.8% | 50.8% | Stock Analytics | |
CIPLA | ₹116,930.0 Cr | -2% | 2% | 53.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹114,416.0 Cr | 1.3% | 8.7% | 26.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,694.0 Cr | -5.5% | 1.3% | 99.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,546.9 Cr | -1.7% | -8% | 28.9% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 1.5% |
-8.1% |
53.1% |
SENSEX | -1.9% |
-0.7% |
18.3% |
You may also like the below Video Courses